文献速递肝病消化道肿瘤与早癌

肝癌中Yes相关蛋白与叉头框M1激活诱导染色体不稳定性

Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
PubMed 文献 · Gastroenterology · 2017-02-27

研究分析242例肝细胞癌转录组数据,发现CIN25和CIN70染色体不稳定基因特征与较短生存或早期复发相关;YAP与FOXM1协同诱导该特征,干扰YAP-TEAD4相互作用或抑制FOXM1可降低染色体不稳定基因表达。

要点

  • CIN25和CIN70基因特征在生存期短或早期复发的肝细胞癌中检出。
  • YAP与FOXM1协同诱导染色体不稳定基因特征表达。
  • 维替泊芬或硫链丝菌素可降低染色体不稳定基因表达模式。

核心结论

  • YAP与FOXM1协同促进染色体不稳定性,干扰该通路的药物可能开发为肝癌治疗手段。

研究设计与样本

  • 分析242例肝细胞癌患者转录组数据,用Kaplan-Meier曲线分析总生存时间和癌症复发。
  • 在Sk-Hep1、SNU182、HepG2或胰腺癌细胞中用小干扰RNA沉默YAP,并用硫链丝菌素或维替泊芬处理。
  • 使用表达组成性活性YAP(YAPS127A)的小鼠,分析肝脏基因表达特征和组织形态学参数,并注射硫链丝菌素后检测。
  • 对105例肝细胞癌和7例非肿瘤肝组织芯片进行免疫组化分析。

主要发现

  • CIN25和CIN70基因表达模式在生存期较短或早期癌症复发的患者肝细胞癌中检出。
  • TEAD4和YAP通过诱导FOXM1并与之结合,是CIN25和CIN70特征表达所必需。
  • 用维替泊芬破坏YAP与TEAD4相互作用,或用硫链丝菌素抑制FOXM1,可降低染色体不稳定基因表达模式。
  • YAPS127A小鼠的增生肝脏和肿瘤中CIN25和CIN70基因表达模式增加,并出现非整倍体和有丝分裂缺陷。
  • 给YAPS127A小鼠注射硫链丝菌素可减少肝脏过度生长和染色体不稳定征象。

临床怎么用

  • 作者认为,干扰YAP-FOXM1通路的药物可能开发为肝癌治疗方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Many different types of cancer cells have chromosome instability. The hippo pathway leads to phosphorylation of the transcriptional activator yes-associated protein 1 (YAP1, YAP), which regulates proliferation and has been associated with the development of liver cancer. We investigated the effects of hippo signaling via YAP on chromosome stability and hepatocarcinogenesis in humans and mice. METHODS: We analyzed transcriptome data from 242 patients with hepatocellular carcinoma (HCC) to search for gene signatures associated with chromosomal instability (CIN); we investigated associations with overall survival time and cancer recurrence using Kaplan-Meier curves. We analyzed changes in expression of these signature genes, at mRNA and protein levels, after small interfering RNA-mediated silencing of YAP in Sk-Hep1, SNU182, HepG2, or pancreatic cancer cells, as well as incubation with thiostrepton (an inhibitor of forkhead box M1 [FOXM1]) or verteporfin (inhibitor of the interaction between YAP and TEA domain transcription factor 4 [TEAD4]). We performed co-immunoprecipitation and chromatin immunoprecipitation experiments. We collected liver tissues from mice that express a constitutively active form of YAP (YAPS127A) and analyzed gene expression signatures and histomorphologic parameters associated with chromosomal instability. Mice were given injections of thiostrepton and livers were collected and analyzed by immunoblotting, immunohistochemistry, histology, and real-time polymerase chain reaction. We performed immunohistochemical analyses on tissue microarrays of 105 HCCs and 7 nontumor liver tissues. RESULTS: Gene expression patterns associated with chromosome instability, called CIN25 and CIN70, were detected in HCCs from patients with shorter survival time or early cancer recurrence. TEAD4 and YAP were required for CIN25 and CIN70 signature expression via induction and binding of FOXM1. Disrupting the interaction between YAP and TEAD4 with verteporfin, or inhibiting FOXM1 with thiostrepton, reduced the chromosome instability gene expression patterns. Hyperplastic livers and tumors from YAPS127A mice had increased CIN25 and CIN70 gene expression patterns, aneuploidy, and defects in mitosis. Injection of YAPS127A mice with thiostrepton reduced liver overgrowth and signs of chromosomal instability. In human HCC tissues, high levels of nuclear YAP correlated with increased chromosome instability gene expression patterns and aneuploidy. CONCLUSIONS: By analyzing cell lines, genetically modified mice, and HCC tissues, we found that YAP cooperates with FOXM1 to contribute to chromosome instability. Agents that disrupt this pathway might be developed as treatments for liver cancer. Transcriptome data are available in the Gene Expression Omnibus public database (accession numbers: GSE32597 and GSE73396).

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Weiler SME, Pinna F, Wolf T, et al. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. Gastroenterology. 2017. PMID: 28249813. doi:10.1053/j.gastro.2017.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。